journal article·2023-06Open access

Bone Lesion‐Derived Extracellular Vesicles Fuel Prometastatic Cascades in Hepatocellular Carcinoma by Transferring ALKBH5‐Targeting miR‐3190‐5p

Shenqi Han, Lin Xue, Yi Wei, Tuying Yong, Wenlong Jia, Yongqiang Qi, Yiming Luo, Junnan Liang, Jingyuan Wen, Nana Bie, Huifang Liang, Qiumeng Liu, Zeyang Ding, Xiangliang Yang, Lu Gan, Zhao Huang, Xiaoping Chen, Bixiang Zhang

Advanced Science· Volume 10· Issue 17

Abstract

Abstract Bone is the second leading metastatic site for hepatocellular carcinoma (HCC). Patients with HCC and bone metastasis suffer poor quality of life and reduced survival time. Extracellular vesicles (EVs) are widely involved in HCC formation and metastasis. However, the communication between primary HCC and bone lesions mediated by EVs remains unclear and the possible effect of bone metastasis on the progression of HCC remains largely unknown. Here, bone‐metastasized HCC‐derived EVs (BM‐EVs) are found to localize to orthotropic HCC cells and promote HCC progression. Mechanistically, miR‐3190‐5p (miR‐3190) is upregulated in intracellular HCC cells isolated from bone lesions as well as in their derived EVs. miR‐3190 in BM‐EVs is transferred into orthotopic tumor cells and enhances their metastatic capacity by downregulating AlkB homolog 5 (ALKBH5) expression. Decreased level of ALKBH5 exacerbates the prometastatic characteristics of HCC by modulating gene expression in N6‐methyladenosine‐dependent and ‐independent ways. Finally, antagomir‐miR‐3190‐loaded liposomes with HCC affinity successfully suppress HCC progression in mice treated with BM‐EVs. These findings reveal that BM‐EVs initiate prometastatic cascades in orthotopic HCC by transferring ALKBH5‐targeting miR‐3190 and miR‐3190 is serving as a promising therapeutic target for inhibiting the progression of HCC in patients with bone metastasis.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Extracellular vesicles in disease · MicroRNA in disease regulation · RNA modifications and cancer

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Hepatic Surgery Center Tongji Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan 430030 China

Clinical Medical Research Center of Hepatic Surgery at Hubei Province Wuhan 430030 China

Hubei Key Laboratory of Hepato‐Pancreatic‐Biliary Diseases Tongji Hospital Tongji Medical College Huazhong University of Science and Technology Wuhan 430030 China

National Engineering Research Center for Nanomedicine College of Life Science and Technology Huazhong University of Science and Technology Wuhan 430074 China

Key Laboratory of Organ Transplantation Ministry of Education Wuhan 430030 China

Key Laboratory of Organ Transplantation National Health Commission Wuhan 430030 China

Funding

National Natural Science Foundation of China · National Key Research and Development Program of China

References (50)

Show source-provided references
1. 10.1038/s41572-020-00216-310.1038/s41572-020-00216-3 ↗
2. 10.1172/JCI14376410.1172/JCI143764 ↗
3. 10.1016/j.cell.2012.10.00510.1016/j.cell.2012.10.005 ↗
4. 10.1016/j.cell.2021.03.01110.1016/j.cell.2021.03.011 ↗
5. 10.1038/s41568-021-00406-510.1038/s41568-021-00406-5 ↗
6. 10.1002/hep.3167310.1002/hep.31673 ↗
7. 10.1002/advs.20200196110.1002/advs.202001961 ↗
8. 10.1007/s11684-022-0928-z10.1007/s11684-022-0928-z ↗
9. 10.1007/s10555-013-9454-410.1007/s10555-013-9454-4 ↗
10. 10.3390/jcm408160010.3390/jcm4081600 ↗
11. 10.7150/thno.5579510.7150/thno.55795 ↗
12. 10.1016/j.cmet.2022.02.00610.1016/j.cmet.2022.02.006 ↗
13. 10.1007/s00268-018-4861-x10.1007/s00268-018-4861-x ↗
14. 10.1002/jev2.1217510.1002/jev2.12175 ↗
15. 10.1016/j.devcel.2019.04.01110.1016/j.devcel.2019.04.011 ↗
16. 10.1016/j.jhep.2020.07.01410.1016/j.jhep.2020.07.014 ↗
17. 10.1038/s41467-017-02583-010.1038/s41467-017-02583-0 ↗
18. 10.1016/j.canlet.2017.03.00410.1016/j.canlet.2017.03.004 ↗
19. 10.1016/j.molcel.2012.10.01510.1016/j.molcel.2012.10.015 ↗
20. 10.1038/s41419-022-05386-410.1038/s41419-022-05386-4 ↗
21. 10.1186/s40164-022-00370-210.1186/s40164-022-00370-2 ↗
22. 10.1186/s12943-020-01239-w10.1186/s12943-020-01239-w ↗
23. 10.1186/s12885-021-08449-510.1186/s12885-021-08449-5 ↗
24. 10.7150/ijbs.7014910.7150/ijbs.70149 ↗
25. 10.1186/s13046-019-1159-210.1186/s13046-019-1159-2 ↗
26. 10.1016/j.jneumeth.2004.05.01310.1016/j.jneumeth.2004.05.013 ↗
27. 10.1038/s41556-022-00893-010.1038/s41556-022-00893-0 ↗
28. 10.1038/ncb200010.1038/ncb2000 ↗
29. 10.1016/j.cell.2009.11.02510.1016/j.cell.2009.11.025 ↗
30. 10.1016/j.ccr.2013.09.00710.1016/j.ccr.2013.09.007 ↗
31. 10.1016/j.cell.2019.02.02910.1016/j.cell.2019.02.029 ↗
32. 10.1016/j.cell.2016.01.04310.1016/j.cell.2016.01.043 ↗
33. 10.1038/nature1111210.1038/nature11112 ↗
34. 10.1016/j.ccell.2017.02.01310.1016/j.ccell.2017.02.013 ↗
35. 10.1016/j.omtn.2021.08.00910.1016/j.omtn.2021.08.009 ↗
36. 10.1038/s41556-021-00835-210.1038/s41556-021-00835-2 ↗
37. 10.1146/annurev-pathol-020117-04385410.1146/annurev-pathol-020117-043854 ↗
38. 10.1016/j.jhep.2016.05.00710.1016/j.jhep.2016.05.007 ↗
39. 10.1166/jbn.2018.261910.1166/jbn.2018.2619 ↗
40. 10.1126/science.aau697710.1126/science.aau6977 ↗
41. 10.1002/jev2.1212510.1002/jev2.12125 ↗
42. 10.1038/nature1575610.1038/nature15756 ↗
43. 10.1002/jev2.1205610.1002/jev2.12056 ↗
44. 10.1186/s13045-022-01224-410.1186/s13045-022-01224-4 ↗
45. 10.1002/cncr.2430010.1002/cncr.24300 ↗
46. 10.1371/journal.pone.010526810.1371/journal.pone.0105268 ↗
47. 10.7150/jca.6530810.7150/jca.65308 ↗
48. 10.1038/s41568-021-00383-910.1038/s41568-021-00383-9 ↗
49. 10.1186/s40425-018-0451-610.1186/s40425-018-0451-6 ↗
50. Campbell J. P. · J. Visualized Exp. · 2012 · 67